Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Manya

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|October 13, 2006
Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycanHui Xiong, Kazuhiro Kobayashi, Masaji Tachikawa, et al.
Cell Reports|March 1, 2016
Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular DystrophyMotoi Kanagawa, Kazuhiro Kobayashi, Michiko Tajiri, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 3, 2017
3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathyMasamichi Nagae, Sushil K Mishra, Makiko Neyazaki, et al.
EMBO Molecular Medicine|January 17, 2015
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's diseaseYasuhiko Kizuka, Shinobu Kitazume, Reiko Fujinawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2016
Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycanNaoyuki Kuwabara, Hiroshi Manya, Takeyuki Yamada, et al.
Human Molecular Genetics|February 25, 2016
Mutations in POMGNT1 cause non-syndromic retinitis pigmentosaMingchu Xu, Takeyuki Yamada, Zixi Sun, et al.
European Journal of Human Genetics : EJHG|January 21, 2011
Congenital muscular dystrophy type 1D (MDC1D) due to a large intragenic insertion/deletion, involving intron 10 of the LARGE geneNigel F Clarke, Svetlana Maugenre, Aurélie Vandebrouck, et al.
Neuromuscular Disorders : NMD|September 18, 2007
Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathiesHiroshi Manya, Céline Bouchet, Akiko Yanagisawa, et al.
Human Molecular Genetics|February 18, 2003
Worldwide distribution and broader clinical spectrum of muscle-eye-brain diseaseKiyomi Taniguchi, Kazuhiro Kobayashi, Kayoko Saito, et al.
Chemistry & Biology|December 22, 2015
Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-MannosylationMoniek Riemersma, D Sean Froese, Walinka van Tol, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|October 13, 2006
Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycanHui Xiong, Kazuhiro Kobayashi, Masaji Tachikawa, et al.
Cell Reports|March 1, 2016
Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular DystrophyMotoi Kanagawa, Kazuhiro Kobayashi, Michiko Tajiri, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 3, 2017
3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathyMasamichi Nagae, Sushil K Mishra, Makiko Neyazaki, et al.
EMBO Molecular Medicine|January 17, 2015
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's diseaseYasuhiko Kizuka, Shinobu Kitazume, Reiko Fujinawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2016
Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycanNaoyuki Kuwabara, Hiroshi Manya, Takeyuki Yamada, et al.
Human Molecular Genetics|February 25, 2016
Mutations in POMGNT1 cause non-syndromic retinitis pigmentosaMingchu Xu, Takeyuki Yamada, Zixi Sun, et al.
European Journal of Human Genetics : EJHG|January 21, 2011
Congenital muscular dystrophy type 1D (MDC1D) due to a large intragenic insertion/deletion, involving intron 10 of the LARGE geneNigel F Clarke, Svetlana Maugenre, Aurélie Vandebrouck, et al.
Neuromuscular Disorders : NMD|September 18, 2007
Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathiesHiroshi Manya, Céline Bouchet, Akiko Yanagisawa, et al.
Human Molecular Genetics|February 18, 2003
Worldwide distribution and broader clinical spectrum of muscle-eye-brain diseaseKiyomi Taniguchi, Kazuhiro Kobayashi, Kayoko Saito, et al.
Chemistry & Biology|December 22, 2015
Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-MannosylationMoniek Riemersma, D Sean Froese, Walinka van Tol, et al.
Pageof 8